Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Genes Chromosomes Cancer

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    December 2022
  1. DROBNA-SLEDZINSKA M, Mackowska-Maslak N, Jaksik R, Kosmalska M, et al
    Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.
    Genes Chromosomes Cancer. 2022;61:720-733.
    PubMed     Abstract available


    November 2022
  2. KABURAGI T, Shiba N, Yamato G, Yoshida K, et al
    UBTF-Internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
    Genes Chromosomes Cancer. 2022 Nov 30. doi: 10.1002/gcc.23110.
    PubMed     Abstract available


    August 2022
  3. RUETHER C, Wuensch C, Randau G, Michgehl U, et al
    Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment.
    Genes Chromosomes Cancer. 2022;61:459-470.
    PubMed     Abstract available


    July 2022
  4. LEE WY, Gutierrez-Lanz EA, Xiao H, McClintock D, et al
    ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations.
    Genes Chromosomes Cancer. 2022;61:399-411.
    PubMed     Abstract available


    June 2022
  5. KOLEILAT A, Smadbeck JB, Zepeda C, Williamson CM, et al
    Characterization of Unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
    Genes Chromosomes Cancer. 2022 Jun 30. doi: 10.1002/gcc.23084.
    PubMed     Abstract available


    May 2022
  6. GAGNON MF, Berg HE, Meyer RG, Sukov WR, et al
    Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: a retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.
    Genes Chromosomes Cancer. 2022 May 31. doi: 10.1002/gcc.23070.
    PubMed     Abstract available


  7. JIANG F, Lang X, Chen N, Jin L, et al
    A Novel HNRNPH1::ERG Rearrangement in Aggressive Acute Myeloid Leukemia.
    Genes Chromosomes Cancer. 2022 May 3. doi: 10.1002/gcc.23051.
    PubMed     Abstract available


    March 2022
  8. GILLAM J, Catic A, Paulraj P, Dalton J, et al
    Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
    Genes Chromosomes Cancer. 2022 Mar 16. doi: 10.1002/gcc.23039.
    PubMed     Abstract available


  9. MACIEL ALT, Wolch K, Emerenciano M, Mansur MB, et al
    CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2022 Mar 6. doi: 10.1002/gcc.23036.
    PubMed     Abstract available


    February 2022
  10. SIEGELE BJ, Stemmer-Rachamimov AO, Lilljebjorn H, Fioretos T, et al
    N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
    Genes Chromosomes Cancer. 2022 Feb 25. doi: 10.1002/gcc.23033.
    PubMed     Abstract available


  11. PATIL P, Hillebrecht S, Chteinberg E, Lopez C, et al
    T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
    Genes Chromosomes Cancer. 2022 Feb 25. doi: 10.1002/gcc.23034.
    PubMed     Abstract available


  12. GAO J, Gurbuxani S, Zak T, Kocherginsky M, et al
    Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
    Genes Chromosomes Cancer. 2022;61:71-80.
    PubMed     Abstract available


    October 2021
  13. LESTRINGANT V, Duployez N, Penther D, Luquet I, et al
    Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Genes Chromosomes Cancer. 2021;60:657-667.
    PubMed     Abstract available


    August 2021
  14. SALIM M, Heldt F, Thomay K, Lentes J, et al
    Cryptic TCF3 fusions in childhood leukemia - detection by RNA-sequencing.
    Genes Chromosomes Cancer. 2021 Aug 30. doi: 10.1002/gcc.22998.
    PubMed     Abstract available


  15. CHEN X, Yuan L, Zhou J, Wang F, et al
    Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with nove
    Genes Chromosomes Cancer. 2021 Aug 21. doi: 10.1002/gcc.22995.
    PubMed    


  16. COSTA D, Granada I, Espinet B, Collado R, et al
    Balanced and unbalanced translocations in a multicentric series of 2,843 patients with chronic lymphocytic leukemia.
    Genes Chromosomes Cancer. 2021 Aug 19. doi: 10.1002/gcc.22994.
    PubMed     Abstract available


  17. ATKIN ND, Raimer HM, Wang Z, Zang C, et al
    Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Genes Chromosomes Cancer. 2021 Aug 18. doi: 10.1002/gcc.22993.
    PubMed     Abstract available


    May 2021
  18. CREASEY T, Enshaei A, Nebral K, Schwab C, et al
    Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2021 May 3. doi: 10.1002/gcc.22956.
    PubMed     Abstract available


    February 2021
  19. AYPAR U, Yao J, Londono DM, Khoobyar R, et al
    Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.
    Genes Chromosomes Cancer. 2021;60:100-107.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: